NBIX- Neurocrine Biosciences, Inc.

Name: Neurocrine Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Gano Kyle	140.4K	$23.32M	-
Other	Benevich Eric	52.8K	$8.76M	-
Other	Lippoldt Darin	46.8K	$7.76M	-
Other	Cooke Julie	39.6K	$6.58M	-36,937
Other	Onyia Jude	36.8K	$6.12M	-22,000

Activity

Buys and sells only

Transactions

10 filings · page 28

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Apr 24, 2020	Grigoriadis Dimitri E.	Chief Research Officer	Sell	1,934	$99.41	$192,258.17	-1.7%
Apr 24, 2020	Gorman Kevin Charles55	Chief Executive Officer	Sell	2,906	$99.45	$289,015.65	-0.7%
Apr 24, 2020	Gano Kyle54	Chief Business Development Off	Sell	1,934	$99.47	$192,376.72	-2.0%
Apr 24, 2020	Cooke Julie59	Chief Human Resources Officer	Sell	1,934	$99.46	$192,363.57	-22.6%
Apr 24, 2020	Bozigian Haig P.	Chief Development Officer	Sell	1,934	$99.46	$192,351.19	-1.3%
Apr 24, 2020	Benevich Eric62	Chief Commercial Officer	Sell	1,934	$99.45	$192,337.85	-12.7%
Apr 24, 2020	Abernethy Matt57	Chief Financial Officer	Sell	1,934	$99.52	$192,466.85	-20.1%
Apr 15, 2020	Benevich Eric62	Chief Commercial Officer	Sell	8,632	$94.65	$817,017.94	-42.7%
Feb 10, 2020	Lloyd-Smith Malcolm49	Chief Regulatory Officer	Sale+OE	29,984	$104.52	$3,133,912.11	-30.1%
Feb 7, 2020	Roberts Eiry49	Chief Medical Officer	Sell	1,623	$103.31	$167,675.38	-17.9%

← PrevPage 28Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC